Prothena Corp Public (PRTA) EPS (Weighted Average and Diluted) (2019 - 2025)
Prothena Corp Public has reported EPS (Weighted Average and Diluted) over the past 10 years, most recently at -$0.4 for Q4 2025.
- Quarterly results put EPS (Weighted Average and Diluted) at -$0.4 for Q4 2025, up 62.62% from a year ago — trailing twelve months through Dec 2025 was -$4.54 (down 98.25% YoY), and the annual figure for FY2025 was -$4.53, down 99.56%.
- EPS (Weighted Average and Diluted) for Q4 2025 was -$0.4 at Prothena Corp Public, up from -$0.68 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for PRTA hit a ceiling of $2.13 in Q3 2021 and a floor of -$2.34 in Q2 2025.
- Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.88 (2022), compared with a mean of -$0.55.
- Biggest five-year swings in EPS (Weighted Average and Diluted): surged 376.62% in 2021 and later plummeted 887.5% in 2023.
- Prothena Corp Public's EPS (Weighted Average and Diluted) stood at -$0.74 in 2021, then skyrocketed by 121.62% to $0.16 in 2022, then plummeted by 887.5% to -$1.26 in 2023, then increased by 15.08% to -$1.07 in 2024, then skyrocketed by 62.62% to -$0.4 in 2025.
- The last three reported values for EPS (Weighted Average and Diluted) were -$0.4 (Q4 2025), -$0.68 (Q3 2025), and -$2.34 (Q2 2025) per Business Quant data.